NCARDIA

In News

Advancing the Future of Cardiac Safety - Fierce Biotech

Fierce Biotech - Sep 24, 2025

An ethical shift in NHP research: iPSC-derived cardiomyocytes for safer pharmacology - Drug Target Review

Drug Target Review - Oct 06, 2025

Automated 3D heart tissue platform speeds up cardiac drug testing - Medical Xpress

Medical Xpress - Jan 22, 2026

The Future of Allogeneic Cell Therapy is Off-the-Shelf and iPSC-Based – An Interview with Cellistic’s Founder and CTO, Stefan Braam, PhD - BioInformant

BioInformant - Oct 23, 2025

Ncardia Launches First-of-Its-Kind iPSC-Derived Non-Human Primate Cardiomyocytes to Advance Cardiac Safety Research - DutchNews.nl

DutchNews.nl - Sep 23, 2025

iPSC technology company Ncardia receives US$60 million investment - RegMedNet

RegMedNet - Nov 17, 2021

Engineering scalable iPSC-NK therapies - European Pharmaceutical Review

European Pharmaceutical Review - Jun 06, 2025

Ncardia Launches Ncyte® Heart in a Box to Advance Cardiovascular Research and Precision Medicine - Business Wire

Business Wire - Jan 27, 2025

Ncardia Expands iPSC Manufacturing and Phenotypic Drug Discovery Services With Support From Investors - BioSpace

BioSpace - Jul 15, 2019

iPSC-derived microglia may help advance ALS research, therapies - ALS News Today

ALS News Today - Jan 30, 2025

Ncardia inks $60M funding deal to expand discovery and commercial production services for stem cells - Fierce Biotech

Fierce Biotech - Nov 16, 2021

Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings - BioInformant

BioInformant - Nov 17, 2021

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment